URACHAL CANCER
Clinical trials for URACHAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URACHAL CANCER trials appear
Sign up with your email to follow new studies for URACHAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: URACHAL CANCER
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 08:52 UTC
-
New hope for hard-to-treat cancers: experimental drug targets HER2-positive tumors
Disease control Recruiting nowThis study tests a drug called trastuzumab rezetecan in people with advanced solid tumors that are HER2-positive and have not responded to standard therapies. About 90 participants with three types of cancer (extramammary Paget's disease, rare solid tumors, or urothelial carcinom…
Matched conditions: URACHAL CANCER
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated May 17, 2026 08:51 UTC